Francisco Javier Llorca Díaz-rekin lankidetzan egindako argitalpenak (7)

2021

  1. Qrisk3 performance in the assessment of cardiovascular risk in patients with inflammatory bowel disease

    Journal of Clinical Medicine, Vol. 10, Núm. 18

2017

  1. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

2015

  1. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 618-626

  2. Cardiovascular risk assessment in rheumatoid arthritis: What goals should be achieved?

    Seminars in Arthritis and Rheumatism

  3. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

  4. Vitamin D deficiency in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology [CARMA] study

    Arthritis Research and Therapy, Vol. 17, Núm. 1

2014

  1. Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 1, pp. 1-8